Niran J. Amar

Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial

John A. Smith, Michael M. Kitt, Alyn H. Morice et al. · The Lancet Respiratory Medicine · 2020 · 216 citations · Full text

Asthma, Pulmonary Care, Phase 2B +6

Long-Term Efficacy and Safety Profile of Rilonacept in the Treatment of Cryopryin-Associated Periodic Syndromes: Results of a 72-Week Open-Label Extension Study

Hal M. Hoffman, M. Throne, Niran J. Amar et al. · Clinical Therapeutics · 2012 · 113 citations

Cryopryin-associated Periodic Syndromes, Long-term Efficacy, Medicine +4

Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis

Gary N. Gross, Gary Berman, Niran J. Amar et al. · Annals of Allergy Asthma & Immunology · 2019 · 61 citations · Full text

Safety and tolerability of a short ragweed sublingual immunotherapy tablet

Hendrik Nolte, Niran J. Amar, David I. Bernstein et al. · Annals of Allergy Asthma & Immunology · 2014 · 51 citations

Allergy Medicine, Medicine, Immunology +4

Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar

Paul H. Ratner, Frank C. Hampel, Niran J. Amar et al. · Annals of Allergy Asthma & Immunology · 2005 · 41 citations

Asthma, Allergy, Allergy Medicine +5